Literature DB >> 32271382

Clinical, Biochemical, and Radiological Profile of Normocalcemic Primary Hyperparathyroidism.

Andrea Palermo1, Anda Mihaela Naciu1, Gaia Tabacco1, Stefania Falcone2, Assunta Santonati3, Daria Maggi1, Luca D'Onofrio4, Silvia Irina Briganti1, Domenico Castellitto5, Alessandro Casini5, Claudio Pedone6, Diana Lelli6, Andrea Fabbri2, John P Bilezikian7, Nicola Napoli1, Paolo Pozzilli1, Silvia Manfrini1, Roberto Cesareo5.   

Abstract

CONTEXT: The clinical and radiological aspects of normocalcemic hyperparathyroidism (NHPT) are confounded by the differing methods used to rule out secondary hyperparathyroidism and by the small sample size.
OBJECTIVE: To assess the clinical, biochemical, and radiological profile of NHPT compared with primary hyperparathyroidism (PHPT) and control subjects.
DESIGN: Multicentric cross-sectional study.
SETTING: Outpatient clinic. PATIENTS: 47 NHPT, 41 PHPT, and 39 age- and sex-matched control subjects. MAIN OUTCOME MEASURES: Calcium metabolism and bone turnover markers (BTMs). Lumbar spine, total hip, femoral neck, one-third distal radius bone mineral density (BMD). Morphometric vertebral fracture (VF) assessed by dual-energy X-ray absorptiometry.
RESULTS: NHPT patients had significantly higher parathyroid hormone, 25(OH)-vitamin D levels and lower calcium × phosphorus product than controls (P < .001). Compared with PHPT, the NHPT group had significantly higher 25(OH) vitamin D levels (P = .016). NHPT had BTM levels similar to controls and PHPT. NHPT, PHPT, and controls have similar lumbar spine and femoral neck BMD. NHPT and controls had a similar radial BMD, while patients with PHPT had a lower radial BMD than both patients with NHPT (P = .031) and controls (P < .05). Using the control group as the reference, after adjustment for interacting factors, there was no increase in risk of moderate-severe VF in NHPT (odds ratio [OR] 1.04, 95% confidence interval [CI] 0.25-4.55), while PHPT had an increased risk (OR 3.81,95% CI 1.15-15.12). Seventy-nine percent of NHPT and 59% of PHPT patients fulfilled the criteria for asymptomatic hyperparathyroidism.
CONCLUSIONS: The biochemical phenotype of NHPT is intermediate between PHPT and controls. In contrast, the bone phenotype resembles controls with normal bone turnover, no significant BMD impairment, and no increased risk of VF. © Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Hyperparathyroidism; PTH; calcium; hypercalcemia; normocalcemic

Mesh:

Substances:

Year:  2020        PMID: 32271382     DOI: 10.1210/clinem/dgaa174

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

1.  PRIMARY HYPERPARATHYROIDISM DETECTED BY PARATHYROID INCIDENTALOMA: CLINICAL FEATURES, WORK-UP AND MANAGEMENT.

Authors:  V Pandzic Jaksic; A Majic; T Rezic; J Andric; O Jaksic; A Zrilic; S Marusic
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Apr-Jun       Impact factor: 0.877

Review 2.  Normocalcaemic primary hyperparathyroidism: what is the role of parathyroid surgery?

Authors:  Nivaran Aojula; Shahab Khan; Neil Gittoes; Zaki Hassan-Smith
Journal:  Ther Adv Endocrinol Metab       Date:  2021-02-27       Impact factor: 3.565

3.  European Expert Consensus on Practical Management of Specific Aspects of Parathyroid Disorders in Adults and in Pregnancy: Recommendations of the ESE Educational Program of Parathyroid Disorders.

Authors:  Jens Bollerslev; Lars Rejnmark; Alexandra Zahn; Ansgar Heck; N M Appelman-Dijkstra; Luis Cardoso; Fadil M Hannan; Filomena Cetani; Tanja Sikjær; Anna Maria Formenti; Sigridur Björnsdottir; Camilla Schalin-Jantti; Zhanna Belaya; Fraser Wilson Gibb; Bruno Lapauw; Karin Amrein; Corinna Wicke; Corinna Grasemann; Michael Krebs; Eeva M Ryhänen; Ozer Makay; Salvatore Minisola; Sebastien Gaujoux; Jean-Philippe Bertocchio; Zaki K Hassan-Smith; Agnès Linglart; Elizabeth M Winter; Martina Kollmann; Hans-Georg Zmierczak; Elena Tsourdi; Stefan Pilz; Heide Siggelkow; Neil J Gittoes; Claudio Marcocci; Peter Kamenicky
Journal:  Eur J Endocrinol       Date:  2022-01-13       Impact factor: 6.664

Review 4.  Phosphate Metabolism and Pathophysiology in Parathyroid Disorders and Endocrine Tumors.

Authors:  Guido Zavatta; Paola Altieri; Giulia Vandi; Valentina Vicennati; Uberto Pagotto; Fabio Vescini
Journal:  Int J Mol Sci       Date:  2021-11-30       Impact factor: 5.923

5.  Comparisons Between Normocalcemic Primary Hyperparathyroidism and Typical Primary Hyperparathyroidism.

Authors:  Hye Ryeon Choi; Sun Hyung Choi; Namki Hong; Yumie Rhee; Jin Kyong Kim; Cho Rok Lee; Sang-Wook Kang; Jandee Lee; Jong Ju Jeong; Kee-Hyun Nam; Woong Youn Chung
Journal:  J Korean Med Sci       Date:  2022-04-04       Impact factor: 2.153

Review 6.  Normocalcemic Primary Hyperparathyroidism: Need for a Standardized Clinical Approach.

Authors:  Guido Zavatta; Bart L Clarke
Journal:  Endocrinol Metab (Seoul)       Date:  2021-06-01

Review 7.  Advances in the diagnosis and the management of primary hyperparathyroidism.

Authors:  Ana Kashfia Islam
Journal:  Ther Adv Chronic Dis       Date:  2021-06-11       Impact factor: 5.091

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.